Macrophage Marker Market Growth Accelerated by increasing Demand from Immunology Research

Macrophage Marker Market


Macrophage markers find extensive applications in molecular biology and immunology research studies. They help identify the phenotype and functions of macrophages in specific tissues under healthy and diseased conditions. The products enable researchers to study the role of macrophages in various immunological disorders and inflammation. They are essential reagents used to characterize monocytes, macrophages, and dendritic cells in flow cytometry and immunohistochemistry experiments.

The global Macrophage Marker Market is estimated to be valued at US$ 295.15 Mn in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing demand from immunology research is expected to drive the market growth over the forecast period. Macrophage markers play a crucial role in understanding the immune response and function of macrophages in various diseases. With the rising incidence of chronic disorders such as cancer and autoimmune diseases, researchers are focusing on elucidating the pathways related to macrophage activation and polarization. This is anticipated to propel the demand for macrophage markers from academic research institutions and biotechnology companies engaged in drug discovery and development activities involving macrophage modulation. Advanced labeling and detection technologies are also fueling the uptake of macrophage markers in research experiments aimed at phenotyping immune cells.

Segment Analysis
The global Macrophage Marker market can be segmented on the basis of marker type, technology, disease indication, and end user. Among marker type, CD68 is dominating the market as it is considered as the gold standard for identifying human macrophages. Between technology, flow cytometry is the most commonly used technique for detecting macrophage markers due to its high sensitivity and specificity.

Key Takeaways
The global Macrophage Marker market is expected to witness high growth. Global Macrophage Marker Market Demand is estimated to be valued at US$ 295.15 Mn in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period 2024 to 2031.

Western Europe region is expected to witness fastest growth during forecast period owing to increasing funding for translational research and biomarker development projects from government organizations in this region. United States currently dominates the North American region and is expected to continue its dominance during forecast period owing to presence of leading market players and research institutes in the country.

Key players operating in the Macrophage Marker market are BD Biosciences, Beckman Coulter, Merck KGaA. BD Biosciences is currently dominating the global market with wide range of monoclonal antibodies for various macrophage markers like CD14, CD163, etc. Beckman Coulter offers comprehensive portfolio of flow cytometry panels with fluorescent conjugated monoclonal antibodies against macrophage markers. Merck KGaA provides reagents and assay kits for detecting macrophage populations from different body fluids including blood, tissue, etc.


Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides